Colgate-Palmolive (NYSE:CL) Price Target Increased to $114.00 by Analysts at JPMorgan Chase & Co.

Colgate-Palmolive (NYSE:CL) had its target price hoisted by JPMorgan Chase & Co. from $113.00 to $114.00 in a research note published on Friday morning, Benzinga reports. The firm currently has an overweight rating on the stock.

Several other research firms also recently commented on CL. Piper Sandler assumed coverage on Colgate-Palmolive in a report on Tuesday, September 24th. They issued an overweight rating and a $121.00 price objective on the stock. Jefferies Financial Group downgraded Colgate-Palmolive from a buy rating to a hold rating and lowered their price objective for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Wells Fargo & Company cut shares of Colgate-Palmolive from an equal weight rating to an underweight rating and set a $100.00 target price on the stock. in a report on Monday, September 16th. TD Cowen increased their price target on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a buy rating in a research report on Tuesday, July 30th. Finally, Citigroup boosted their price objective on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the company a buy rating in a research report on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of Moderate Buy and an average price target of $106.00.

Colgate-Palmolive Stock Performance

NYSE:CL opened at $100.10 on Friday. The company has a market capitalization of $82.13 billion, a price-to-earnings ratio of 31.68, a PEG ratio of 3.54 and a beta of 0.40. The business has a 50 day moving average of $103.56 and a 200 day moving average of $97.15. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a 1-year low of $68.54 and a 1-year high of $109.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The firm had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. During the same period in the previous year, the business posted $0.77 EPS. The business’s quarterly revenue was up 4.9% on a year-over-year basis. On average, sell-side analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Insider Activity

In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Gregory Malcolm sold 10,533 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at approximately $1,069,868.70. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.34% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Several large investors have recently bought and sold shares of the business. E Fund Management Hong Kong Co. Ltd. purchased a new stake in Colgate-Palmolive during the 2nd quarter valued at $25,000. Continuum Advisory LLC boosted its position in Colgate-Palmolive by 46.5% in the second quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock worth $38,000 after purchasing an additional 125 shares during the last quarter. Rise Advisors LLC bought a new stake in shares of Colgate-Palmolive during the 1st quarter valued at about $38,000. Voisard Asset Management Group Inc. purchased a new stake in shares of Colgate-Palmolive during the 4th quarter valued at about $40,000. Finally, Register Financial Advisors LLC bought a new position in shares of Colgate-Palmolive in the 1st quarter worth approximately $48,000. 80.41% of the stock is currently owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.